BOSTON, Massachusetts, May 29 -- Mass General Brigham issued the following news release:

* * *

Sean M. Healey & AMG Center for ALS Announces Design of TPN-101 for the Treatment of ALS in HEALEY ALS Platform Trial

The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH) is pleased to announce the initiation of a new HEALEY ALS Platform Trial regimen design for TPN-101 in collaboration with Transposon Therapeutics, Inc.

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Submit Form Click here for more information about our products